Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Unknown × Inflammation × Clear all

Phase

Phase NA 10 Phase 4 2 Phase 3 1 Phase 1/2 1 Phase 1 1

Status

Completed 2 Unknown 1 Terminated 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 59 Breast Neoplasms 55 Leukemia, Myeloid, Acute 51 Neoplasms 50 Multiple Myeloma 41 Lymphoma 41 Stomach Neoplasms 40 Carcinoma, Hepatocellular 39 Colorectal Neoplasms 38 Recurrence 35 Pancreatic Neoplasms 34 Neoplasm Metastasis 33 Melanoma 33 Prostatic Neoplasms 29 Leukemia 27 Ovarian Neoplasms 24 Lymphoma, Non-Hodgkin 22 Lung Neoplasms 22 Lymphoma, Large B-Cell, Diffuse 20 Glioblastoma 20 Hematologic Neoplasms 19 Myelodysplastic Syndromes 18 Lymphoma, B-Cell 18 Precursor Cell Lymphoblastic Leukemia-Lymphoma 17 Lymphoma, Mantle-Cell 17 Leukemia, Lymphocytic, Chronic, B-Cell 17 Colonic Neoplasms 17 Esophageal Neoplasms 16 Sarcoma 15 Carcinoma, Renal Cell 15

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02759601 2018-12-20

CHR-2845

Queen Mary University of London

Phase 1/2 Unknown

Gastrointestinal

Carcinoma, Hepatocellular, Inflammation

Data powered by HemOnc (CC BY 4.0) Colophon ⚡